1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Parmax Pharma
Parmax Pharma Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Parmax Pharma Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
83.38% Gain from 52W Low
22.4
Dividend yield 1yr %
0
Parmax Pharma Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
43.60
10Day EMA
43.40
12Day EMA
43.40
20Day EMA
43.10
26Day EMA
43.00
50Day EMA
42.80
100Day EMA
42.50
200Day EMA
40.90
5Day SMA
44.00
10Day SMA
43.20
20Day SMA
43.00
30Day SMA
42.50
50Day SMA
42.80
100Day SMA
43.20
150Day SMA
43.60
200Day SMA
41.40
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2651 Rs | 5707 Rs |
Week Rs | 1061 Rs | 1899 Rs |
Month Rs | 376 Rs | 582 Rs |
Resistance & Support
44.71
Pivot
Resistance
First Resistance
48.13
Second Resistance
50.35
Third Resistance
53.77
Support
First Support
42.49
Second support
39.07
Third Support
36.85
Relative Strength Index
54.76
Money Flow Index
74.74
MACD
0.38
MACD Signal
0.34
Average True Range
3.56
Average Directional Index
13.02
Rate of Change (21)
12.20
Rate of Change (125)
15.15
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Chemo Pharma Laboratories Ltd. | - | - | - | |
Phaarmasia Ltd. | - | - | - | |
Span Divergent Ltd. | - | - | - | |
Colinz Laboratories Ltd. | - | - | - | |
Norris Medicines Ltd. | - | - | - | |
Parmax Pharma Ltd. | - | - | - | |
Sunrest Lifescience Ltd. | - | - | - |
Parmax Pharma Company background
Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Parmax Pharma FAQs
How to buy Parmax Pharma shares?
You can easily buy Parmax Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Parmax Pharma stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
